| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PSMB1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | CNTD1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | CHCHD7 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | ITPRIPL1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | FLVCR1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | ZNF730 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | BOLA2B | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | PDP2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | DCP2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | GFI1B | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
